Lifeway Foods, Inc. LWAY

21.74 (0.17) (0.78%) as of 25 Sep
Market cap
$331.0M
P/E
30.2×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Insider Decisions

Total buys 14.58
Total sells 92.96
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — 2 — — 2 —
Sell 1 — 3 — — 3 1 3 5 3 1 —
Insider Ownership 35.23%

Capital & Financial Ratios

Market Cap 330.99
Revenue 242.41
Net Income 10.87
Free Cash Flow (30.89)
Net Debt 14.86
Current Ratio 2.09
Debt/Equity 0.26
P/E ratio 30.19
P/S ratio 1.36
P/B ratio 3.90
Past 5Y EPS Growth 83.46%
This Y EPS Growth (41.60%)
Next Y EPS Growth 145.87%
Next 5Y EPS Growth 18.74%
in millions of $

Dividends

Payout Ratio 0.00
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2021 Powerpack
2020 Powerpack
2019 Powerpack
2018 Powerpack
2017 Powerpack
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 13 17 6 7
Receivables 14 16 17 24
Inventory 9 9 12 14
Other — — — —
38 44 37 47
2023 2024 2025 Q'26
Payables 10 10 11 17
ST’ Debt — — — —
Other — — — —
17 16 17 23
in millions of $

Compound Annual Growth

10y 5y 3y
Sales 6.01% 15.81% 14.50%
Cash Flow 4.96% 11.39% 40.03%
Earnings 21.53% 33.80% 146.62%
Book Value 6.61% 12.87% 21.74%

Revenue

Mar Jun Sep Dec Year
’26 63 67 — — —
’25 46 54 57 55 212
’24 45 49 46 47 187
’23 38 39 41 42 160
’22 34 33 38 36 142
’21 29 29 30 31 119
’20 25 25 26 26 102
in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

Mar Jun Sep Dec Year
’26 4 0 — — —
’25 0 4 7 0 11
’24 2 7 7 (3) 13
’23 3 2 7 5 17
’22 (1) 0 4 0 4
’21 1 2 2 0 6
’20 (1) 3 3 1 6
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Mar Jun Sep Dec Year
’26 (7) (9) — — —
’25 (2) 2 2 (17) (16)
’24 (1) 5 6 (4) 6
’23 1 2 6 4 13
’22 (1) (1) 3 0 1
’21 1 2 2 (1) 4
’20 (1) 3 3 0 4
in millions of $ · fiscal quarters ending in the months shown

EPS

Mar Jun Sep Dec Year
’26 0.30 0.01 — — —
’25 0.23 0.28 0.23 0.16 0.89
’24 0.16 0.25 0.19 (0.01) 0.60
’23 0.06 0.21 0.23 0.26 0.75
’22 (0.06) 0.01 0.06 0.05 0.06
’21 0.08 0.10 0.03 (0.01) 0.21
’20 0.01 0.06 0.12 0.02 0.20
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
8.68 7.20 1.81 1.84 1.43 4.51 4.55 5.26 9.93 19.50

Analyst estimates 2026–2028

Powerpack
Low Price
18.48 12.09 8.66 4.75 8.89 7.20 9.00 17.33 28.61 34.20
High Price
320 340 322 307 316 282 291 289 291 295
Employees
0 0 0 0 0 0 0 1 1 1
Revenue/Emp
124 119 103 94 102 119 142 160 187 212
Revenue
28.28% 25.82% 25.02% 23.65% 26.40% 24.11% 18.92% 26.51% 26.00% 27.39%
Gross Margin
6 (1) (3) 1 5 6 2 17 14 20
EBT
4.55% (0.68%) (3.20%) 1.32% 4.73% 4.72% 1.30% 10.40% 7.48% 9.26%
EBT Margin
3 0 (3) 0 3 3 1 11 9 14
Net Income
3 3 5 3 3 3 3 3 3 4
Depreciation
7.67 7.38 6.51 5.95 6.54 7.66 9.20 10.92 12.65 13.98
Revenue/Sh
0.22 (0.02) (0.19) 0.03 0.21 0.21 0.06 0.77 0.61 0.91
Earnings/Sh
0.32 0.24 0.15 0.24 0.41 0.36 0.26 1.16 0.88 0.72
Cash Flow/Sh
(0.19) (0.33) (0.17) (0.04) (0.12) (0.12) (0.22) (0.29) (0.45) (1.79)
Capex/Sh
0.13 (0.09) (0.02) 0.20 0.29 0.23 0.03 0.86 0.43 (1.07)
Free CF/Sh
2.99 2.89 2.67 2.75 3.00 3.16 3.09 4.12 4.87 5.65
Book Value/Sh
16 16 16 16 16 16 15 15 15 15
Shares
52.09 0.00 0.00 56.21 25.76 22.45 97.23 17.17 40.00 26.63
PE Ratio
1.46 1.14 0.29 0.33 0.83 0.60 0.61 1.23 1.96 1.73
PS Ratio
3.74 2.90 0.70 0.72 1.80 1.45 1.82 3.25 5.09 4.29
PB Ratio
1.44 1.12 0.32 0.33 0.78 0.58 0.63 1.16 1.88 1.72
EV/Sales
87.50 (89.96) (108.37) 9.68 17.66 19.11 164.79 14.73 56.07 (22.41)
EV/FCF
5 4 2 4 6 6 4 17 13 11
Op' Cash Flow
(3) (5) (3) (1) (2) (2) (3) (4) (7) (27)
Capex
2 (1) 0 3 4 4 1 13 6 (16)
FCF
18 11 11 10 16 17 14 22 28 20
Working Cap'
6 3 6 3 3 6 5 1 — —
Total Debt
(3) (2) 3 (1) (5) (3) 1 (12) (17) (6)
Net Debt
48 47 42 43 47 49 48 60 72 86
Sh' Equity
5.35% (0.53%) (5.09%) 0.80% 5.47% 5.01% 1.32% 15.09% 10.48% 14.13%
ROA
8.30% (0.74%) (4.28%) (2.87%) 7.38% 7.96% 3.03% 21.80% 15.69% 12.60%
ROIC
7.43% (0.73%) (6.94%) 1.06% 7.17% 6.90% 1.91% 21.05% 13.64% 17.57%
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Lifeway Foods, Inc. peers in Packaged Foods

All 71 Packaged Foods stocks →

Lifeway Foods, Inc. (LWAY) key facts

  • Lifeway Foods, Inc. (LWAY) is a Packaged Foods company in the Consumer Defensive sector, listed on Nasdaq.
  • Lifeway Foods, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $212.5 million, up 13.7% from fiscal 2024.
  • Net income was $13.9 million, or $0.91 per share (basic), a net margin of 6.52%.
  • As of September 25, 2026, LWAY traded at $21.74, a market capitalization of $331.0 million.
  • At that price the stock trades at 30.2× trailing-twelve-month earnings and 1.4× sales.
  • Return on equity was 17.6% and debt-to-equity 0.26.

Source: company filings (standardised) and stockrow calculations.

Lifeway Foods, Inc. (LWAY) Latest News

News by impact score

Fine-tune

15 Aug

3 transcript

Lifeway Foods reported record sales for Q2 2026 amid ongoing cost pressures. Record sales signal revenue strength while cost pressures constrain margin gains and limit overall trajectory shift.

13 Aug

4

Lifeway Foods reports highest quarterly net sales in company history for second quarter 2026, extending its record growth streak. Record net sales growth signals strong momentum that can lift financial results and investor sentiment.

3 transcript

Lifeway Foods Q2 earnings call covered financial results, operational updates and management outlook for the company. Earnings call details typically influence near-term stock sentiment and valuation without guaranteeing long-term structural change.

24 Jul

3

Lifeway Foods (LWAY) gains from rising consumer health trends. Consumer health trends boost Lifeway Foods performance and market position.

9 Jun

3

Lifeway Foods, Inc. removes poison pill ahead of shareholders’ meeting. Poison pill removal raises takeover risk and may shift control dynamics ahead of the vote.

8 Jun

4

Key Lifeway Foods shareholder Edward Smolyansky states termination of the poison pill marks an inflection point for shareholders as governance questions mount ahead of the election. Poison pill termination and governance issues ahead of election signal potential control shifts that can alter company trajectory.

19 May

4

Danone exits its stake in Lifeway Foods Inc. Danone stake sale changes ownership structure and drives major shifts in Lifeway Foods investor sentiment and stock trajectory.

18 May

4

Danone will sell its stake in Lifeway Foods. Danone stake sale creates major ownership shift and sharp market reaction for Lifeway.

4

Danone plans to sell its stake in Lifeway Foods Inc. Danone stake sale triggers major ownership shift with direct effects on Lifeway stock and strategy.

14 May

5

Lifeway Foods announces record-breaking results for the first quarter ended March 31, 2026. Record-breaking Q1 results indicate transformative financial growth and enhanced long-term prospects for Lifeway Foods.

4

Lifeway Foods Inc (LWAY) reported record sales in Q1 2026 earnings call, highlighting strategic initiatives amid strong performance. Record sales and strategic initiatives represent major positive developments likely to enhance financial performance and investor sentiment.

3

Lifeway Foods, Inc. released Q1 2026 earnings call summary detailing financial results, operational updates, and forward guidance. Quarterly earnings call summary reveals financial performance and strategic outlook with moderate influence on market perception.

3

Lifeway Foods, Inc. (LWAY) announced the pricing of a secondary underwritten public offering of its common stock. Secondary offering increases share float, likely causing moderate short-term price pressure but limited long-term impact.

23 Apr

3

Lifeway Foods, Inc. (LWAY) partners with Erewhon to launch Tropical Lifeway Smoothie made with organic Lifeway Kefir. Partnership launches new kefir-based smoothie at premium retailer Erewhon, supporting product innovation and visibility with moderate impact.

1 Apr

4

Lifeway Foods, Inc. (LWAY) projects 32% to 35% growth for first quarter 2026 amid surging momentum. 32% to 35% Q1 growth projection signals major boost to revenue trajectory and investor sentiment.

17 Mar

5

Lifeway Foods announced strong fourth quarter and record-breaking full year 2025 results, led by its flagship Kefir product. Record-breaking full-year results driven by flagship Kefir represent a game-changing positive shift for LWAY's competitive position and long-term prospects.

4

Lifeway Foods Inc. (LWAY) reported record sales in Q4 2025 earnings call, highlighting strategic initiatives amid strong performance. Record sales and strategic highlights signal significant boosts to financial trajectory and investor confidence.

4

Lifeway Foods Q4 earnings call highlights key financial results, strategic updates, and forward guidance for the company. Q4 earnings call highlights detail financial performance and future outlook, significantly impacting investor sentiment and market trajectory.

4

Lifeway Foods, Inc. (LWAY) released Q4 earnings snapshot reporting key financial results for the quarter. Q4 earnings snapshot reveals financial performance metrics that significantly affect stock valuation and future market trajectory.

27 Feb

3

Lifeway Foods celebrates 40 years of kefir leadership by unveiling new cultured dairy innovations at Expo West 2026. New product innovations at a major trade expo signal moderate advancements in competitive positioning and potential sales growth.

5 Feb

3

Lifeway Foods, Inc. launched a social media campaign featuring Colston Loveland and D'Andre Swift to promote its kefir products during the Big Game weekend. The campaign aims to engage consumers through social-first strategies, leveraging the popularity of the event and the influencers involved to boost brand visibility and sales. The campaign is expected to moderately influence brand awareness and sales, but its overall impact on the company's long-term trajectory remains limited.

2 Feb

4

Lifeway Foods, Inc. (LWAY) faces significant challenges that could impact its future performance. The company has struggled with declining sales and increased competition in the probiotic market. Analysts express concerns over its ability to innovate and adapt to changing consumer preferences. Additionally, financial metrics indicate potential liquidity issues, raising questions about its long-term viability. The overall market sentiment towards LWAY remains cautious as investors weigh these factors against the company's strategic initiatives. Declining sales and increased competition could significantly alter the company's trajectory and investor sentiment.

30 Jan

3

Lifeway Foods, Inc. has introduced a new Power Play Shake, enriched with kefir, to support Barry's 'Find Your Strength' challenge. This shake aims to provide a nutritious option for participants looking to enhance their fitness journey. The collaboration highlights Lifeway's commitment to promoting health and wellness through innovative products. The launch of a new product targeting fitness enthusiasts may positively influence brand perception and sales, but its overall impact on the company's trajectory is expected to be limited.

13 Jan

4

Lifeway Foods, Inc. has launched Probiotic Kefir Butter™, a premium European-style cultured butter that combines the health benefits of probiotics with the rich flavor of traditional butter. This new product is designed to cater to health-conscious consumers seeking high-quality dairy options. The introduction of Probiotic Kefir Butter™ aligns with Lifeway's commitment to innovation in the dairy sector and expands its product line in the cultured dairy market. The launch of a new premium product is likely to significantly impact Lifeway's market positioning and consumer interest.

8 Jan

4

Lifeway Foods, Inc. anticipates record-breaking results for 2025, driven by strong demand for its kefir products. The company also announced its participation in the upcoming ICR Conference, highlighting its commitment to growth and innovation in the health food sector. Record-breaking expectations and participation in a significant conference indicate major strategic moves that could enhance market positioning.

7 Jan

4

Lifeway Foods, Inc. commends the new federal dietary guidelines that emphasize the importance of protein, full-fat dairy, and fermented foods such as kefir. The company views these guidelines as aligning with its product offerings and promoting health benefits associated with its dairy products. The new dietary guidelines could significantly boost demand for Lifeway's kefir and dairy products, impacting market performance positively.

31 Dec

4

Lifeway Foods, Inc. (LWAY) is highlighted as one of three growth companies favored by insiders, indicating potential for significant future performance. The company is noted for its innovative product offerings in the health and wellness sector, which align with current consumer trends. Insider buying activity suggests confidence in the company's strategic direction and growth prospects. Investors may find Lifeway Foods an attractive option as it continues to expand its market presence and capitalize on the increasing demand for probiotic and functional foods. Insider buying activity and innovative product offerings suggest significant confidence in the company's growth trajectory.

19 Dec

3

Edward Smolyansky, CEO of Lifeway Foods, Inc., responded to the ISS board recommendation regarding the company's governance and strategic direction. He emphasized the importance of shareholder engagement and outlined the company's commitment to enhancing value through innovation and operational efficiency. Smolyansky's remarks reflect a proactive approach to addressing investor concerns and positioning Lifeway for future growth amidst competitive market dynamics. The response to ISS indicates a focus on governance and shareholder engagement, which may moderately influence investor sentiment and operational strategies.

18 Dec

3

Lifeway Foods, Inc. has received a recommendation from Institutional Shareholder Services (ISS) supporting its nominees for the board of directors. This endorsement is significant as it may influence shareholder voting and bolster the company's governance structure. The recommendation comes amid ongoing efforts by Lifeway to enhance its strategic direction and operational performance. The ISS recommendation could moderately influence shareholder sentiment and governance, impacting the company's strategic direction.

15 Dec

4

Edward Smolyansky, a shareholder of Lifeway Foods, Inc. (LWAY), has released key deposition insights urging investors to withhold votes for legacy directors Dorri McWhorter, Julie Smolyansky, and Jason Scher. His call for action highlights concerns regarding the company's governance and leadership, potentially impacting shareholder confidence and future decision-making. Concerns raised about governance and leadership could significantly influence investor sentiment and the company's strategic direction.

stockrow.com/LWAY · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com